A Phase I/II Study of Erlotinib and Romidepsin in Advanced Non-Small Cell Lung Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 01 Dec 2015
At a glance
- Drugs Romidepsin (Primary) ; Erlotinib
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Mar 2011 New trial record